Baseline infection | 6 month | Repeat infection | P-Valuea | |
---|---|---|---|---|
IFNα | 12.1 (1.6–24.2) | 0.8 (0.8–2.6) | 0.8 (0.8–0.8) | 0.004 |
IFNγ | 1.5 (1.5–8.9) | 1.7 (1.5–10.3) | 1.54 (1.5–10.6) | 0.714 |
IL1β | 1.5 (1.5–1.5) | 1.57 (1.5–1.5) | 1.57 (1.5–1.5) | . |
IL12p40 | 1.0 (1.0–1.0) | 1.0 (1.0–1.0) | 1.0 (1.0–1.0) | . |
IL12p70 | 1.6 (1.6–1.6) | 1.6 (1.6–1.6) | 1.6 (1.6–1.6) | . |
IP-10 | 855.4 (372.7–1143.6) | 672.9 (602.6–941.6) | 626.3 (462.0–740.4) | 0.424 |
MCP-1 | 242.1 (212.8–303.1) | 278.37(259.2–312.2) | 260.7 (225.8–294.0) | 0.533 |
CCL3 | 1.6 (1.6–4.9) | 1.6 (1.6–1.6) | 1.6 (1.6–1.6) | 0.127 |
CCL4 | 17.5 (4.9–32.8) | 12.4 (3.5–16.6) | 0.9 (0.9–12.1) | 0.022 |
IL-4 | 1.6 (1.6–1.6) | 1.6 (1.6–1.6) | 1.6 (1.6–1.6) | . |
IL-5 | 1.6 (1.6–1.6) | 1.6 (1.6–1.6) | 1.6 (1.6–1.6) | . |
IL-6 | 1.3 (1.3–1.3) | 1.3 (1.3–1.3) | 1.3 (1.3–1.3) | . |
IL-7 | 1.1 (1.1–1.6) | 1.1 (1.1–1.1) | 1.1 (1.1–1.1) | . |
IL-8 | 2.5 (1.6–5.6) | 1.6 (1.6–4.1) | 2.1 (1.6–2.4) | 0.265 |
IL-10 | 1.5 (1.5–31.5) | 3.3 (1.9–8.4) | 1.8 (1.8–1.9) | 0.787 |
IL-17A | 1.5 (1.5–1.5) | 1.5 (1.5–1.5) | 1.5 (1.5–1.5) | 0.489 |
RPR titre | 128 (64–128) | 8 (2–16) | 32 (16–128) | 0.07 |